Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
The specialty pharmaceutical company Warner Chilcott announced on 18 April 2011 that it would restructure its western Europe operations and cut around a fifth of its workforce following the fact that its key osteoporosis drug (Actonel) lost exclusivity in 2010. The company has said that the restructuring will take place in Belgium, the Netherlands, France, Germany, Italy, Spain, Switzerland and the UK, but will not impact its operations at its headquarters in Dublin, Ireland. It expects the restructuring to be completed by the end of 2012.
Eurofound (2011), Warner Chilcott, Internal restructuring in European Union, factsheet number 71887, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/71887.